Clinical pharmacology in health care service

Clinical pharmacology in health care service

Saved in:

Bibliographic Details
Main Author:	Janković Slobodan M.
Format:	Article
Language:	English
Published:	Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2005-01-01
Series:	Vojnosanitetski Pregled
Subjects:	pharmacology clinical quality assurance health care drug interactions adverse drug reaction reporting systems
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500510757J.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical pharmacology in Serbia: The time for new challenges
by: Dragojević-Simić Viktorija, et al.
Published: (2007-01-01)

Pharmacovigilance in clinical trials
by: Ilić Katarina, et al.
Published: (2007-01-01)

Exposure to potential drug-antimicrobial agent interactions in primary health care
by: Nikolić Božana, et al.
Published: (2018-01-01)

Clinical and pharmacological monitoring of drug safety in pediatrics
by: N. V. Verlan, et al.
Published: (2016-05-01)

Polypharmacy, drug–drug interactions and adverse drug reactions in older Chinese cancer patients: evidence from CHARLS
by: Zijun Yan, et al.
Published: (2025-05-01)

Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors
by: Janković Slobodan M., et al.
Published: (2011-01-01)

Methodology for Creating a Risk Management System for Drug-Drug Interactions
by: A. A. Taube, et al.
Published: (2024-03-01)

Prevalence and clinical significance of potential drug-drug interactions of antimicrobials in Intensive Care Unit patients: a retrospective study
by: Shanshan Xu, et al.
Published: (2025-05-01)

Practical aspects of apixaban use in clinical practice: continuing the theme
by: S. N. Bel'diev
Published: (2015-11-01)

Associations between Suspected Adverse Drug Reactions of HMG-CoA Reductase Inhibitors and Polypharmacology Using a National Registry Approach
by: Hasan Yousaf, et al.
Published: (2024-07-01)

Impact of pharmacological services in delivering quality health care - An Orthopaedic Unit experience from a tertiary care Medical College
by: Melvin J. George, et al.
Published: (2025-04-01)

KNOWLEDGE, ATTITUDE AND PRACTICE AMONG HEALTHCARE PROFESSIONALS TOWARDS ADR REPORTING IN ABBOTTABAD PAKISTAN
Published: (2021-12-01)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022-06-01)

Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries
by: Mohammed Gebre Dedefo, et al.
Published: (2025-08-01)

Integrating pharmacovigilance into the routine of pharmacy department: experience of nine years
by: Ariadna Pérez-Ricart, et al.
Published: (2019-07-01)

Review of the textbook “Clinical and pharmacological characteristics of biotechnological drugs: from classifications to adverse events”
by: V. I. Petrov
Published: (2024-04-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

Rational Organisation of Adverse Drug Reaction Monitoring
by: L. V. Shukil, et al.
Published: (2022-10-01)

Pharmacovigilance as an imperative of modern medicine - experience from Montenegro
by: Mugoša Snežana, et al.
Published: (2017-01-01)

Risk factors for severe adverse drug reactions in hospitalized patients
by: Petrović Nemanja Z., et al.
Published: (2025-01-01)

Effectiveness of mobile applications in enhancing adverse drug reaction reporting: a systematic review
by: Liyanage PH, et al.
Published: (2025-05-01)

Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice
by: Michela De Bellis, et al.
Published: (2025-07-01)

Synthesis and Pharmacology of Clinical Drugs Containing Isoindoline Heterocycle Core
by: Mukund Jha, et al.
Published: (2025-01-01)

Cutaneous adverse drug reactions and their impact on the quality of life of patients: a study at a tertiary care centre
by: Shivani, et al.
Published: (2025-07-01)

A Case Series of Different Cutaneous Adverse Drug Reactions Attending the Dermatology Clinic of a Tertiary Care Center
by: Debalina Kanjilal, et al.
Published: (2025-06-01)

Spontaneous Adverse Drug Reaction Reporting of Congenital Malformations: A Danish National Register Study
by: Ulrik Lausten-Thomsen, et al.
Published: (2025-06-01)

Adverse events associated with herbal medicine products reported in the Korea Adverse Event Reporting System from 2012 to 2021
by: Yujin Choi, et al.
Published: (2024-10-01)

Optimization of antidepressant treatment by pharmacogenomics: a case report
by: Ying Zhang, et al.
Published: (2025-01-01)

MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE
by: N. V. Verlan, et al.
Published: (2017-02-01)

A realworld pharmacovigilance study of trazodone based on the FDA adverse event reporting system
by: Yong Yu, et al.
Published: (2025-02-01)

User’s evaluation about quality of the service in emergency care unit
by: Maycon Rogério Seleghim, et al.
Published: (2010-06-01)

Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases
by: Chunsu Liang, et al.
Published: (2024-12-01)

Possible Association Between Concomitant Use of SSRIs with NSAIDs and an Increased Risk of Adverse Events Among People with Depressive Disorders: Data Mining of FDA Adverse Event Reporting System
by: Yi Zhang, et al.
Published: (2025-07-01)

Current issues related to the off-label use of drugs and their potential solutions
by: K. S. Radaeva, et al.
Published: (2024-04-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
by: O. V. Shatalova, et al.
Published: (2015-09-01)

Oropharyngeal adverse drug reactions: knowledge, attitudes, and practice (KAP) among Italian healthcare professionals and students
by: Gaetano La Mantia, et al.
Published: (2025-04-01)

Evaluation of Oral Antidiabetes Drugs in Patients of Uncontrolled Type 2 Diabetes Mellitus: A Cohort Study
by: Samiksha J Sonar, et al.
Published: (2025-04-01)

Andrographolide Sulfonates and Xiyanping: A Review of Chemical Composition, Pharmacological Activities, Clinical Applications, and Adverse Reactions
by: Zihong Li, et al.
Published: (2025-01-01)

An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to study the cardiac adverse reactions and mechanism of action of osimertinib
by: Wenjuan Wang, et al.
Published: (2025-06-01)

PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST
by: D. A. Sychev, et al.
Published: (2015-09-01)